Insmed Incorporated
Trade Insmed Incorporated 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About INSM
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.
INSM Key Statistics
Stock Snapshot
Insmed Incorporated(INSM) stock is priced at $120.50, giving the company a market capitalization of 26.2B. It carries a P/E multiple of -29.23.
As of 2026-09-20, Insmed Incorporated(INSM) stock has fluctuated between $119.40 and $124.11. The current price stands at $120.50, placing the stock +0.9% above today's low and -2.9% off the high.
Insmed Incorporated(INSM) shares are trading with a volume of 3.44M, against a daily average of 2.2M.
During the past year, Insmed Incorporated(INSM) stock moved between $90.39 at its lowest and $212.75 at its peak.
During the past year, Insmed Incorporated(INSM) stock moved between $90.39 at its lowest and $212.75 at its peak.
INSM News
has seen its stock reshape over the past few years, and the question now is whether the current price is supported by what the business is generating in sales....
Roth Capital analyst Adam Walsh lowered the firm’s price target on Insmed (INSM) to $198 from $212 and keeps a Buy rating on the shares. The firm has lowered it...
Analyst ratings
100%
of 24 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.